OTC · Financial Statements

Item 9 Labs Corp. (INLB) Financial Statements

$0.00 OTC: INLB Market Cap $70181

Item 9 Labs Corp. most recently reported annual revenue of $22.0M, net profit of $-31.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20182019202020212022
Revenue$1.0M$5.0M$8.0M$22.0M$22.0M
Operating Profit$-1.0M$-4.0M$-5.0M$-6.0M$-23.0M
Net Profit$-1.0M$-11.0M$-12.0M$-11.0M$-31.0M
EPS$-0.23$-0.17$-0.20$-0.14$-0.33
Op Margin-50.3%-88.8%-65.6%-25.5%-106.0%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$4.0M$14.0M$21.0M$117.0M$111.0M
Total Liabilities$1.0M$7.0M$13.0M$31.0M$49.0M
Cash$0$0$0$1.0M$0
Borrowings$0$5.0M$8.0M$21.0M$28.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-1.0M$-2.0M$-1.0M$-6.0M$-2.0M
Investing Cash Flow$-1.0M$-14.0M$-1.0M$-6.0M$-11.0M
Financing Cash Flow$1.0M$9.0M$0$0$0
Net Cash Flow$0$-1.0M$0$1.0M$-1.0M
Free Cash Flow$-2.0M$-9.0M$-2.0M$-8.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.22
FCF Yield-10989.73%
Quick Ratio0.03
Interest Coverage-3.60
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
INLB Overview INLB Dividend Run Stock Screener